KARO vs DBD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
KARO
DBD
Investment Advisor Scores
DBD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | KARO | DBD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 25.3807 | 12.1655 | DBD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 22.5% | 1.7% | KARO |
| Earnings Growth | 11.4% | 34.2% | DBD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.1/100 | 59.7/100 | DBD |
| Profit Margin | 17.8% | 2.9% | KARO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
KARO
MarkupPrice above SMA50, rising 50-day trend (12.7% over 20 days), RSI 58
DBD
MarkdownPrice below a falling SMA50 (slope -1.4%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | KARO | DBD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 1.7 | 10.0 |
| Trailing P/E | 30.1 | 22.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.7% | 0.3% |
| Operating Margin | 0.3% | 0.1% |
| EPS | 2.09 | 3.04 |
| Dividend Yield | 0.35% | — |